3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Hepatocellular
6
Neoplasms
2
Pancreatic Neoplasms
1
Liver Cirrhosis
1
Infections
1
Hepatitis D
1
Hepatitis C, Chronic
1
Hepatitis C
1
Hepatitis B, Chronic
1
Hepatitis B
1
Fibrosis
1
Esophageal and Gastric Varices
1
Colonic Neoplasms
1
Interventions
Blood Specimen Collection
6
Magnetic Resonance Spectroscopy
4
Tenofovir
3
Liver Transplantation
3
Specimen Handling
2
Sorafenib
2
Simvastatin
2
tremelimumab
1
sonidegib
1
sofosbuvir-velpatasvir drug combination
1
peginterferon alfa-2a
1
navitoclax
1
maltodextrin
1
hepatitis B hyperimmune globulin
1
durvalumab
1
contrast agent BR1
1
bavituximab
1
atezolizumab
1
apixaban
1
adefovir dipivoxil
1
Viusid
1
Vitamin D
1
User-Centered Design
1
Surveys and Questionnaires
1
Sunitinib
1
Spermine Synthase
1
Sonazoid
1
Sampling Studies
1
Radiotherapy
1
Radiofrequency Ablation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fibrosis
×
peginterferon alfa-2a
×
Gastrointestinal
×
Clear all
NCT05683548
2025-02-17
RCAP
Replicor Inc.
No longer available